Anaplastic lymphoma kinase tyrosine kinase inhibitor-induced hepatic failure in lung cancer patients: A study of signal mining and analysis of the FDA adverse event reporting system database.

Zhou, Ziye; Wang, Chenxiang; Ying, Lili; Jin, Mi; Zhang, Fangfang; Shi, Dawei

Zhou, Ziye; Wang, Chenxiang; Ying, Lili; Jin, Mi; Zhang, Fangfang; Shi, Dawei.

Afiliación

Zhou Z; Department of pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wang C; Department of pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Ying L; Department of pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jin M; Department of pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zhang F; Department of pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Shi D; Department of pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

J Clin Pharm Ther ; 46(4): 1148-1154, 2021 Aug.

Article en En | MEDLINE | ID: mdl-33768534

Asunto(s)

Quinasa de Linfoma Anaplásico/antagonistas & inhibidores; Antineoplásicos/efectos adversos; Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico; Fallo Hepático/inducido químicamente; Neoplasias Pulmonares/tratamiento farmacológico; Adulto; Anciano; Antineoplásicos/uso terapéutico; Teorema de Bayes; Bases de Datos Factuales; Femenino; Humanos; Masculino; Persona de Mediana Edad; Estudios Retrospectivos

Palabras clave

alectinib; anaplastic lymphoma kinase tyrosine kinase inhibitors; ceritinib; crizotinib; hepatic failure; hepatic necrosis; hepatitis fulminant; lung cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fallo Hepático / Carcinoma de Pulmón de Células no Pequeñas / Quinasa de Linfoma Anaplásico / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google